Search Results 221-230 of 14499 for albumin

1. A Study to Evaluate the Safety, Tolerability, Drug/Body Interactions, and Activity of Oradoxel for Patients with Advanced Malignancies - Mayo Clinic

   ... albumin. Adequate renal function as demonstrated by serum creatinine ≤ 1.5 x ULN or creatinine clearance>60 mL/min as calculated by the Cockroft and Gault ...

2. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

   Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...

3. Toxicology and Pharmacology Shared Resource - Department of Molecular Medicine - Mayo Clinic Research

   ... albumin (ALB) g/dL and total protein (TP) g/dL. To run this test, 150 µL of blood mixed well in a green top, lithium heparin tube (Greiner Bio-One ...

4. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

   Participation eligibility · Albumin below < 3 . · INR > 1.3 unless due to therapeutic anticoagulants NOTE: INR may be repeated once to reassess eligibility.

5. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   Serum albumin > 28 g/L - Lipase < 2 ULN - Urine protein/ creatinine ratio (UPCR) =< 1. Prothrombin time (PT)/ international normalized ratio (INR) and ...

6. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   Serum albumin ≥ 2.8 g/dl;; Serum creatinine ≤ 2.0 X ULN or calculated creatinine clearance ≥ 30 mL/min (≥ 0.5 mL/sec) using the Cockcroft-Gault equation ...

7. EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx - Mayo Clinic

   Serum albumin <3.0 g/dL unless prothrombin time is within the normal range. Pregnancy or lactation. For female patients of childbearing potential (defined ...

8. Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer - Mayo Clinic

   Albumin ≥ 2.0 g/dL; Neutrophil count >1200/mm³ (1.2x10⁹/L). Exclusion Criteria: History of hepatic encephalopathy; Contraindications to angiography and ...

9. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Albumin ≥ 2.5mg/dL;; Creatinine ≤ 1.5 X upper limit of normal (ULN). NOTE: measured or calculated (per institutional standard) creatinine clearance is ...

10. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

    Serum albumin 2.5 g/dL. Exclusion Criteria: Is "treatment-naïve" (i.e., has not received at least 1 anti-folate and platinum combination regimen). Has ...